National and Kapodistrian University of Athens
Αποφρακτική αρτηριοπάθεια κάτω άκρων: σύγχρονη διάγνωση και θεραπεία
Abstract
dc:descriptionThe purpose of our study was to evaluate a) the technical success of percutaneous transluminal angioplasty (PTA) and stent or stent - graft placement b) the clinical success - outcome, and c) the long - term patency rates, in patients with peripheral vascular disease (PVD). This study preferably focuses on symptomatic patients with atherosclerotic disease located in the femoropopliteal artery. Our study included 40 limbs. If invasive treatment is indicated, balloon angioplasty of shortfemoropopliteal artery stenoses is the accepted procedure of choice because of the high technical success rate, the low invasiveness and the good long - term patency rates. At 1 year, persistent relief of clinical symptoms can be expected in 60% - 80% of patients with intermittent claudication or critical limb ischemia. The 3-year clinical patency rate (symptomatology) may approach 50% - 70% in claudicators. If balloon angioplasty fails, secondary stent placement is indicated with patency rates similar to those for PTA if short lesions are treated. However, primary stent placement is not indicated because it does not result in higher patency rates compared with PTA and is not cost-effective. In longer obstructions (greater than 10cm in length) the initial technical success rate is still over 90% but the long-term patency rates are only 22% - 69% at 1 year. Due to the low invasiveness of PTA, with a major complication rate of less than 5% and the low mortality rate (<1%) PTA is the recommended initial therapeutic strategy for segmented femoropopliteal lesions. After recanalization of occlusions up to 10cm in length, there may be an increase need for stents or stent -grafts due to inadequate results from PTA alone. We believe that the use of ePTFE -covered endoprosthesis actually improves long-term patency. Lesions longer than 10cm should be treated primarily by bypass surgery and not by PTA. However, PTA may be the only option if surgery is contraindicated. We believe, even though-our experience is limited, that endovascular placement of stent grafts will result in patency rates comparable to the results for bypass surgery. However, this must be proven by a long-term randomized study with more patients. Our study included only 9 patients. Medical treatment with platelet inhibitory drugs should be initiated in all patients with PVD, after an endoluminal intervention with a combined regimen of acetylsalicylic acid, and dipyridamole. A close surveillance program should be instituted at least within the first 2 years to enable reintervention if a re-obstruction occurs. This program should include at a minimum, recording of the clinical status, the pulse status and the ankle brachial Doppler index (ABI). Last, but not least we should emphasize the necessity of a more close cooperation between the clinical doctor (angiosurgeant) and the interventional radiologist. We feel that is the contributor to successful results in our department.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kelekis, Anastasios
- Κελέκης, Αναστάσιος
Subjects
dc:subject × 16- Απόφραξη
- Στένωση αορτής
- Μηροϊγνυακός άξονας
- Διαδερμική αγγειοπλαστική
- Τοποθέτηση διαδερμικής ενδαυλικής πρόθεσης
- Τοποθέτηση επικαλυμμένης ενδαυλικής πρόθεσης
- Superficial femoral artery
- Femoropopliteal occlusions and stenoses
- Percutaneous transluminal angioplasty (PTA)
- Stent-placement
- Occlussions
- Stenosis
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/22464